UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 163

Sortiert nach

Association of Vitamin D Levels With Multiple Sclerosis Activity and Progression in Patients Receiving Interferon Beta-1b

JAMA neurology, 2015-12, Vol.72 (12), p.1458

2015

Link zum Volltext

Verfügbarkeit prüfen

Rapid Immune Responses to a Botulinum Neurotoxin Hc Subunit Vaccine through In Vivo Targeting to Antigen-Presenting Cells

Infection and Immunity, 2011-08, Vol.79 (8), p.3388-3396

2011

Link zum Volltext

Verfügbarkeit prüfen

Terbutaline in myasthenia gravis: A pilot study

Journal of the neurological sciences, 2009-02, Vol.277 (1), p.150-154

2009

Link zum Volltext

Verfügbarkeit prüfen

Treatment of Infantile Spasms: Emerging Insights From Clinical and Basic Science Perspectives

Journal of Child Neurology, 2011-11, Vol.26 (11), p.1411-1421

2011

Link zum Volltext

Verfügbarkeit prüfen

Interferon-β corrects massive gene dysregulation in multiple sclerosis: Short-term and long-term effects on immune regulation and neuroprotection

EBioMedicine, 2019-11, Vol.49, p.269-283

2019

Link zum Volltext

Verfügbarkeit prüfen

IMMUNOLOGIC THERAPY OF MULTIPLE SCLEROSIS

Annual review of medicine, 1999-01, Vol.50 (1), p.291-302

Arnason, MD, Barry G. W

1999

Link zum Volltext

Verfügbarkeit prüfen

Olig1 is expressed in human oligodendrocytes during maturation and regeneration

Glia, 2011-06, Vol.59 (6), p.914-926

2011

Link zum Volltext

Verfügbarkeit prüfen

Anti-S-Nitrosocysteine Antibodies Are a Predictive Marker for Demyelination in Experimental Autoimmune Encephalomyelitis: Implications for Multiple Sclerosis

The Journal of neuroscience, 2002-01, Vol.22 (1), p.123-132

2002

Link zum Volltext

Verfügbarkeit prüfen

A novel Fcγ receptor ligand augments humoral responses by targeting antigen to Fcγ receptors

European Journal of Immunology, 2007-04, Vol.37 (4), p.1139-1148

2007

Link zum Volltext

Verfügbarkeit prüfen

Immunoglobulin-like transcript 3, an inhibitor of T cell activation, is reduced on blood monocytes during multiple sclerosis relapses and is induced by interferon beta-1b

Multiple sclerosis, 2010-01, Vol.16 (1), p.30-38

2010

Link zum Volltext

Verfügbarkeit prüfen

Long-term experience with interferon beta-1b (Betaferon)in multiple sclerosis

Journal of neurology, 2005-09, Vol.252 Suppl 3 (S3), p.iii28-iii33

Arnason, Barry G W

2005

Link zum Volltext

Verfügbarkeit prüfen

A phase 3 trial of extended release oral dalfampridine in multiple sclerosis

Annals of neurology, 2010-10, Vol.68 (4), p.494-502

2010

Link zum Volltext

Verfügbarkeit prüfen

The Brain and Host Defense

1, 2009

Link zum Volltext

Verfügbarkeit prüfen

Sustained-release oral fampridine in multiple sclerosis: a randomised, double-blind, controlled trial

The Lancet (British edition), 2009-02, Vol.373 (9665), p.732-738

2009

Link zum Volltext

Verfügbarkeit prüfen

All-trans retinoic acid potentiates the ability of interferon beta-1b to augment suppressor cell function in multiple sclerosis

Archives of neurology (Chicago), 1998-03, Vol.55 (3), p.315

1998

Link zum Volltext

Verfügbarkeit prüfen

Dose comparison trial of sustained-release fampridine in multiple sclerosis

Neurology, 2008-10, Vol.71 (15), p.1134

2008

Link zum Volltext

Verfügbarkeit prüfen

Etretinate augments interferon beta-1b effects on suppressor cells in multiple sclerosis

Archives of neurology (Chicago), 2001-01, Vol.58 (1), p.87

2001

Link zum Volltext

Verfügbarkeit prüfen

Axonal metabolic recovery in multiple sclerosis patients treated with interferon β-1b

Journal of neurology, 2001-11, Vol.248 (11), p.979-986

2001

Link zum Volltext

Verfügbarkeit prüfen

Cross-sectional study assessing long-term safety of interferon-beta-1b for relapsing-remitting MS

Neurology, 2010-06, Vol.74 (23), p.1877

2010

Link zum Volltext

Verfügbarkeit prüfen

Detection of in Vivo Stimulated Cerebrospinal-Fluid Lymphocytes by Flow Cytometry in Patients with Multiple Sclerosis

The New England journal of medicine, 1980-09, Vol.303 (13), p.713-717

1980

Link zum Volltext

Verfügbarkeit prüfen

Immunoglobulin-like transcript 3, an inhibitor of T cell activation, is reduced on blood monocytes during multiple sclerosis relapses and is induced by interferon β-Ib

Multiple sclerosis, 2010, Vol.16 (1), p.30-38

2010

Link zum Volltext

Verfügbarkeit prüfen

Short communication: Terbutaline in myasthenia gravis: A pilot study

Journal of the neurological sciences, 2009-02, Vol.277 (1-2), p.150-154

2009

Link zum Volltext

Verfügbarkeit prüfen

Axonal metabolic recovery in multiple sclerosis patients treated with interferon beta-1b

Journal of neurology, 2001-11, Vol.248 (11), p.979-986

2001

Link zum Volltext

Verfügbarkeit prüfen

Optimizing Outcomes in Multiple Sclerosis – A Consensus Initiative

Multiple sclerosis, 2009-02, Vol.15 (2_suppl), p.1-4

2009

Link zum Volltext

Verfügbarkeit prüfen

Variability in detection and quantification of interferon β-1b-induced neutralizing antibodies

Journal of neuroinflammation, 2012-06, Vol.9 (1), p.129-129, Article 572

2012

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 163

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(135)
Mit Volltextzugriff
(136)

Publikationsform

Artikel
(151)
Buchkapitel
(10)
Bücher
(1)
Berichte
(1)

Sprache

Englisch
(163)
Japanisch
(8)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Association of Vitamin D Levels With Multiple Sclerosis Activity and Progression in Patients Receiving Interferon Beta-1b

Rapid Immune Responses to a Botulinum Neurotoxin Hc Subunit Vaccine through In Vivo Targeting to Antigen-Presenting Cells

Terbutaline in myasthenia gravis: A pilot study

Treatment of Infantile Spasms: Emerging Insights From Clinical and Basic Science Perspectives

Interferon-β corrects massive gene dysregulation in multiple sclerosis: Short-term and long-term effects on immune regulation and neuroprotection

IMMUNOLOGIC THERAPY OF MULTIPLE SCLEROSIS

Olig1 is expressed in human oligodendrocytes during maturation and regeneration

Anti-S-Nitrosocysteine Antibodies Are a Predictive Marker for Demyelination in Experimental Autoimmune Encephalomyelitis: Implications for Multiple Sclerosis

A novel Fcγ receptor ligand augments humoral responses by targeting antigen to Fcγ receptors

Immunoglobulin-like transcript 3, an inhibitor of T cell activation, is reduced on blood monocytes during multiple sclerosis relapses and is induced by interferon beta-1b

Long-term experience with interferon beta-1b (Betaferon)in multiple sclerosis

A phase 3 trial of extended release oral dalfampridine in multiple sclerosis

The Brain and Host Defense

Sustained-release oral fampridine in multiple sclerosis: a randomised, double-blind, controlled trial

All-trans retinoic acid potentiates the ability of interferon beta-1b to augment suppressor cell function in multiple sclerosis

Dose comparison trial of sustained-release fampridine in multiple sclerosis

Etretinate augments interferon beta-1b effects on suppressor cells in multiple sclerosis

Axonal metabolic recovery in multiple sclerosis patients treated with interferon β-1b

Cross-sectional study assessing long-term safety of interferon-beta-1b for relapsing-remitting MS

Detection of in Vivo Stimulated Cerebrospinal-Fluid Lymphocytes by Flow Cytometry in Patients with Multiple Sclerosis

Immunoglobulin-like transcript 3, an inhibitor of T cell activation, is reduced on blood monocytes during multiple sclerosis relapses and is induced by interferon β-Ib

Short communication: Terbutaline in myasthenia gravis: A pilot study

Axonal metabolic recovery in multiple sclerosis patients treated with interferon beta-1b

Optimizing Outcomes in Multiple Sclerosis – A Consensus Initiative

Variability in detection and quantification of interferon β-1b-induced neutralizing antibodies

Suchergebnisse filtern